Patients with early breast cancer benefit from effective axillary treatment
- Cite this article as:
- Harris, J.R. & Osteen, R.T. Breast Cancer Res Tr (1985) 5: 17. doi:10.1007/BF01807645
- 35 Downloads
We have reviewed the available clinical data on the benefit of axillary treatment in patients with early breast cancer. The results of these studies suggest that perhaps 5–10% of patients are cured by effective axillary treatment. We conclude that effective axillary treatment should still be considered an essential aspect of primary treatment.